Trial of Controversial Alzheimer’s Drug Halted After Disappointing Resultsnews2024-11-26T01:42:26+00:00November 26th, 2024|The New York Times|
Purdue Opioid Settlement on Verge of Collapse After Supreme Court Rulingnews2024-06-27T19:56:56+00:00June 27th, 2024|The New York Times|
Supreme Court Seems Inclined to Reject Bid to Curtail Abortion Pill Accessnews2024-03-27T00:24:42+00:00March 27th, 2024|The New York Times|
The Challenges of Teaching Constitutional Law Todaynews2024-03-11T20:05:31+00:00March 11th, 2024|The New York Times|
Journal Retracts Studies Cited in Federal Court Ruling Against Abortion Pillnews2024-02-09T23:07:08+00:00February 9th, 2024|The New York Times|
Monsanto Should Pay $857 Million in PCB Case, Jury Findsnews2023-12-19T02:53:57+00:00December 19th, 2023|The New York Times|
Justice Dept. Asks Supreme Court to Hear Abortion Pill Casenews2023-09-08T23:06:10+00:00September 8th, 2023|The New York Times|
F.D.A. Approves First U.S. Over-the-Counter Birth Control Pillnews2023-07-13T14:32:37+00:00July 13th, 2023|The New York Times|
FDA Makes Alzheimer’s Drug Leqembi Widely Accessiblenews2023-07-06T21:26:16+00:00July 6th, 2023|The New York Times|
Gilead Wins Key Patent Rights Suit Over HIV Prevention Drug PrEPnews2023-05-09T17:34:57+00:00May 9th, 2023|The New York Times|
